India's Pharmaceutical Exports

Country Profile

Lithuania

Lithuania is an emerging destination for Indian pharmaceutical exports — $17.9M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $839K. The compound annual growth rate since FY2015 stands at 4.1%.

🇱🇹 $17.9M · 1.6× growth since FY2015 · 4.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$17.9M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.1%
CAGR FY2015→2026
68%
Medicines Share
5
Product Categories Supplied
Lithuania is an emerging destination for Indian pharmaceutical exports — $17.9M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $839K. The compound annual growth rate since FY2015 stands at 4.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $12.2M (68.5%) Medicine Ingredients $3.77M (21.1%) Vaccines $839K (4.7%) Surgical & Hospital Supplies $564K (3.2%) Traditional & Herbal $454K (2.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Lithuania in the RBI overseas direct investment dataset (2011–2026).